Live Chat

Novavax 거래 NVAX

매도
 매수

Novavax 실시간 차트

5m 15m 30m 1h 4h 1d 1w

상품 기초

Weekly Search
Weekly
Daily
날짜 종료 변경 변동(%) 열기 높음 낮음

최신 뉴스

A graph showing us stock futures mildly decline after S&P 500 record close.
Vanessa L 2025 Jan 24, 06:30

US Stock Futures Decline After S&P 500 Record Close

Shares Stocks US500
Hand holding mobile with Tesla logo and upward stock arrow, reflecting Tesla Model Y price increase.
Vanessa L 2025 Jan 23, 11:00

Tesla Model Y Price Hike Sparks Debate Across Canada

TSLA Stocks Shares
Gold bullion and U.S. dollar bills, reflecting trends in gold coin prices.
Vanessa L 2025 Jan 23, 10:20

Gold Coin Prices Steady Amid Dollar Weakness

Gold USD Commodities Fed
Apple stock news with Chinese flag on smartphone, highlighting market challenges.
Vanessa L 2025 Jan 23, 08:30

Apple Stock News Amid Revenue Diversification

Stocks Shares AAPL China
BOJ rate hike
Tommy Yap 2025 Jan 22, 17:00

Morning Note: BOJ’s Rate Hike: How Will It Shape Markets?

BoJ Forex
Netflix app logo on smartphone, representing "do Netflix stocks stay good or bad."
Vanessa L 2025 Jan 22, 12:30

Trump Stock Market & Netflix Stock Outlook

Stocks US500 USD Shares
Oil prices
Tommy Yap 2025 Jan 21, 17:00

Morning Note: How Trump's Energy Plan and Global Market Trends Are Shaping Investments

Oil
Frances Wang 2025 Jan 21, 16:00

NFLX stock News today: Netflix stock jumped over 14%

Stocks

정보

스프레드

0.07

스프레드(%)

0.7376 %

레버리지

1:10

익일 이자 매수

-0.0597 %

익일 이자 매도

-0.0292 %

통화

USD

거래 시간

시장 폐장

금요일

14:31 - 20:59

월요일

14:31-20:59

화요일

14:31-20:59

수요일

14:31-20:59

목요일

14:31-20:59

분석 및 통계

열기

---

이전 종가

---

52주 최고/최저

--- – ---

시가총액

1414433408

발행 주식 수

160184992

수익 날짜 (다음)

2019-05-10

배당수익률

2019-05-10

배당락일

예상 연간 배당금

0

예상 연간 배당수익률

0

EPS

-2.18

이 상품에 대해 자세히 알아보기

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

관련 상품

자산
매도
매수
변동(%)

지금 거래하기

지금 거래하기

지금 거래하기

지금 거래하기
view_all_instruments
Trustpilot
Live Chat